top of page
cdc-Omo_QaQChIM-unsplash.jpg

Advanced Antimicrobial Stewardship Program

This program is designed to meet the ongoing educational needs for those practitioners who have stewardship practice experience and/or basic education and skills training in this area of practice. The entire didactic component is presented at the Annual Meeting.

A practical component, designed by the learner and completed at their place of practice, is also required for Program completion.

 

This Advanced Antimicrobial Stewardship Training Program satisfies all ACPE requirements for certificate programs and addresses such topics as stewardship application, collecting and analyzing stewardship metrics, and novel approaches to promote stewardship programs and initiatives. In addition to the opportunity to earn a certificate of completion, participants will earn up to 20.50 hours of continuing pharmacy or medical education (2.05 CEU).

Global Learning Objectives The overall or Global Learning Objectives for the Advances Program do not change from year-to-year. While content for the live portion of the program varies from year-to-year, each year’s learning objectives serve to address the global objectives. The Global Objectives for the program are to: -List and apply advances in antimicrobial stewardship at the participant’s home institution/health system. -Describe the latest changes in antimicrobial resistance of clinical relevance to therapeutics both nationally and internationally. -Understand and apply advances in antimicrobial therapeutics, including such things as new agents, new vaccines and pharmacodynamics principles to patient care at the patient and system levels. -Describe changes in the regulatory landscape relevant to the management of patients with infectious diseases and their implications for antimicrobial stewardship programs. -Apply both epidemiologic and infection control and susceptibility surveillance methods, including the use of electronic data capture software, to assist in the analysis and interpretation of data reflecting anti-infective use, stewardship programs/interventions, and antimicrobial resistance -Prepare a plan to measure both patient outcome and economic impact of stewardship programs/initiatives at the institutional level -Propose methods for assessing quality improvement through local national and international benchmarking techniques -Prepare and implement an ongoing plan to successfully cost-justify new and established stewardship programs -Describe advances in diagnostic techniques (e.g., rapid molecular tests, biomarkers) and propose methods to incorporate their use/application to stewardship initiatives -Describe and defend how clinical pathways and other system-based approaches help influence appropriate antibiotic selection and use -Describe various methods to collaborate locally, regionally, nationally and internationally in advancing the science and practice of antimicrobial stewardship

Part 1: Live Component; 2022 Program Learning Objectives At the conclusion of this activity, learners should be able to: 1. Identify the optimal treatment for challenging multiply resistant gram negative infections. 2. Discuss the current therapeutic gaps in treatment of invasive fungal infections. 3. Review the major controversies published in the ID literature from May 2023 thru April 2024. 4. Describe the core principles and objectives of diagnostic stewardship. 5. Assess the clinical and economic impact of C. difficile infections recurrence. 6. Illustrate the significance of antiretroviral therapy errors that occur in HIV patients who are hospitalized. 7. Summarize current controversies in antimicrobial therapy and resistance. 8. Evaluate factors that impact the health wellness of healthcare workers. 9. Explain how implementation science addresses gaps in process and patient outcomes. 10. Present the process, benefits and limitations of penicillin skin testing. 11. Consider why the emergency and urgent care settings are critical targets for antimicrobial stewardship programs. 12. Describe how infectious diseases and antimicrobial stewardship pharmacists can leverage. patient engagement in scarce resource allocation, risk management, and education/outreach. 13. Review the available evidence to support shorter courses of therapy for common uncomplicated infections. 14, Outline the basic concepts supporting antibiotic dose-response relationships. 15. Discuss antimicrobial use strategies to improve the outcomes of patients with septic shock.

Part 2: Practical Component The Practical Component represents a demonstration of application of acquired knowledge and skills, and is completed at the applicant’s site of practice. It entails 6 CE hours but no additional fees. *The practical component should be completed within 12 months of the date of completion of Part 1 of the live sessions. For more detailed information, specific instructions on completing the practical component please see practicum guidelines page.

Accreditation MAD-ID is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MAD-ID will award a maximum of 22.00 hours (2.2 CEU) for pharmacists. MAD-ID reports to the National Association of Boards of Pharmacy via CPE Monitor. Continuing education credit will be awarded for all successfully completed live sessions regardless of whether the full Program in completed. The practical component is accredited for 6.00 credit hours (0.6 CEU). This activity has been planned and implemented in accordance with the accreditation requirement and policies of the Accreditation Council for Continuing Medical Education (ACCME). MAD-ID is accredited by the ACCME to provide continuing medical education (CME) for physicians. MAD-ID designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. MAD-ID does not accredit the practical component (practicum) for AMA PRA Category 1 Credits™. Learners should claim only the credit commensurate with the extent of their participation in the activity. Nurse Practitioners and Registered Nurses For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. Physician Assistants The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. Canadian Accreditation The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities. European Accreditation Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credits™ to an equivalent number of European CME Credits® (ECMEC®s). Information on the process of converting AMA PRA Category 1 Credits™ to ECMEC®s can be found at: www.eaccme.eu.

Registration Fees Regular Registration Fees: Registration Fee (2021); paid when registering for annual meeting$225.00 Group Registration Fees are available (groups from same institution): 5 or more participants$215.00 per person

bottom of page